LAVA Therapeutics NV (LVTX) — Financial Flexibility Index
LAVA Therapeutics NV (LVTX) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of $-4.87 Million (operating CF $-4.87 Million minus capex $0.00) represents 0% of total liabilities ($39.23 Million). Check LVTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LAVA Therapeutics NV Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for LAVA Therapeutics NV across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does LAVA Therapeutics NV generate cash.
Annual Financial Flexibility Index for LAVA Therapeutics NV (2019–2024)
Year-by-year free cash flow to debt coverage for LAVA Therapeutics NV. Explore LAVA Therapeutics NV (LVTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.37x | $-19.52 Million | $-19.54 Million | $53.09 Million | ▲ +53.0% |
| 2023 | -0.78x | $-39.55 Million | $-40.28 Million | $50.53 Million | ▼ -1070.1% |
| 2022 | 0.08x | $4.63 Million | $4.04 Million | $57.38 Million | ▲ +106.0% |
| 2021 | -1.34x | $-27.88 Million | $-28.65 Million | $20.88 Million | ▼ -95.1% |
| 2020 | -0.68x | $-8.80 Million | $-9.31 Million | $12.87 Million | ▲ +74.3% |
| 2019 | -2.66x | $-7.85 Million | $-8.62 Million | $2.95 Million | — |